Form 4: Aquestive Therapeutics Executive Lori Braender Reports Stock Transactions
SEC Form 4 Filing
Lori Braender, Chief Legal Officer of Aquestive Therapeutics, reports acquisition and disposal of company stock and stock options.
Summary
- Lori Braender, Chief Legal Officer of Aquestive Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On March 7, 2025, Ms. Braender acquired 110,000 shares of common stock at $0 and disposed of 9,592 shares at $2.65 to cover tax obligations related to vesting Restricted Stock Units (RSUs).
- On March 9, 2025, Ms. Braender disposed of 10,658 shares at $2.65 to cover tax obligations related to vesting Restricted Stock Units (RSUs).
- Ms. Braender also acquired 60,000 non-qualified stock options with an exercise price of $2.65, vesting in three annual installments, and expiring on March 7, 2035.
- Following these transactions, Ms. Braender beneficially owns 402,981 shares of common stock and 60,000 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing represents routine transactions related to compensation and tax obligations.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly diluting the stock due to the issuance of new shares for option exercises, but this is a standard part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Acquisition of 110,000 shares of common stock and disposal of 9,592 shares for tax obligations; grant of 60,000 non-qualified stock options. |
| 03/09/2025 | Disposal of 10,658 shares for tax obligations. |
| 03/11/2025 | Date of Form 4 signature. |
| 03/07/2035 | Expiration date of the non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.